Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Thousand Oaks Biopharmaceuticals is a leading China-based integrated CDMO specializing in biologics. The company has delivered nearly 100 biologic CMC projects and offers end-to-end services from cell line development through commercial manufacturing. Its pipeline includes biosimilars and innovative biologics with some programs reaching NDA/BLA stage and others in early clinical development[5][9].
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Thousand Oaks Biopharmaceuticals.